ToxIC Representing at #ACMT2025

We are pleased to share that the Toxicology Investigators Consortium (ToxIC) will be present with an exciting line-up of orginal research and poster presentations at the ACMT Annual Scientific Meeting April 4-6 in Vancouver Canada. Check out some highlights and the full schedule below!

POSTERS
Presenter	Dataset	Title	Presentation Time
Michelle Hieger	Core Registry	Age-Related Survival Outcomes of Extracorporeal Membrane Oxygenation in Acutely Poisoned Patients: A Decade-Long Analysis	4/4 at 11:00 – 12:00PM Poster Session 1
Yaron Finkelstein	Core Registry	Severe Outcomes Following Intoxication by Attention Deficit and Hyperactivity Disorder Medications	4/6 at 12:45 – 1:45PM Poster Session 3
Allison Font	Core Registry	Characteristics and Outcomes of Pediatric Nicotine Exposures Described in the Toxicology Investigators Consortium (ToxIC) Core Registry	4/5 at 10:45 – 11:45AM Poster Session 2
Alyssa Falise	DOTS	First Intranasal Naloxone Dose Among Patients with Confirmed Opioid-Related Overdoses Doesn’t Predict Naloxone Response	4/5 at 10:45 – 11:45AM Poster Session 2
Keshav Reddy	DOTS	Evaluation of Sociodemographic Differences in Xylazine Versus Non-Xylazine Exposures	4/5 at 10:45 – 11:45AM Poster Session 2
Sara Walton	DOTS	Regional Trends for Drugs and Novel Psychoactive Substances (NPS) from Emergency Department Patients in the United States	4/4 at 11:00 – 12:00PM Poster Session 1
Samantha Gaetani	DOTS	Buprenorphine Administration and Addiction Treatment after Non-Fatal Opioid Overdoses: A Multicenter Study	4/5 at 10:45 – 11:45AM Poster Session 2
Jennifer Love	Fentalog	Alpha-2 Agonist in Opioid Overdose Is Not Associated with Prolonged Emergency Department Sedation	4/4 at 11:00 – 12:00PM Poster Session 1
Rachel Culbreth	Fentalog	Identifying patterns of polydrug combinations in emergency department patients with confirmed opioid overdose using latent class analysis	4/5 at 10:45 – 11:45AM Poster Session 2
Brianne Cregan	Fentalog	Are There Demographic Differences in Patients with a Suspected Opioid Overdose based on Co-Exposure to Novel Psychoactive Substances?	4/5 at 10:45 – 11:45AM Poster Session 2
Melissa Alvarez	Fentalog	Trends in Synthetic Cannabinoid Use Among Opioid Overdose Cases in the United States	4/5 at 10:45 – 11:45AM Poster Session 2
Spencer Greene	NASBR	Once, Twice, Three Times a Bite Victim: Recidivism in Snake Envenomation	4/6 at 12:45 – 1:45PM Poster Session 3
MODERATED POSTER
Rachel Culbreth	DOTS	Xylazine knowledge and beliefs in patients presenting to the emergency department with an opioid or stimulant overdose	4/6 at 12:45 – 1:45PM Moderated Poster Forum 3
Jeffrey Smith	DOTS	Opioid Overdose Among People Who Intend to Only Use Illicit Stimulants	4/5 at 10:45 – 11:45AM Moderated Poster Forum 2
Spencer Greene	NASBR	Medical Toxicology: A Safety Net for Snakebite Victims	4/4 at 11:00 – 12:00PM Moderated Poster Forum 1
LIGHTNING ORAL
James Whitledge	Core Registry	Drug Shortage Outcomes and Solutions Reported to the ToxIC Registry over a 22-Month Period	4/6 at 8:00 – 9:00AM Lightening Oral Session
Jessica Kent		Characterization of Nitazene Involved Overdose Deaths in Ontario, Canada	4/6 at 8:00 – 9:00AM Lightening Oral Session
PLATFORM SESSION
Evan Schwarz	DOTS	Xylazine Blood Concentrations Are Not Associated With Clinical Severity After an Opioid Overdose	4/5 at 8:00 – 9:00AM Platform Session 2
CONCURRENT SESSION
Alyssa Falise, Rachel Culbreth, & Hannah Spungen	Original Research	Leveraging Epidemiology in Medical Toxicology Investigations	4/4 at 3:30 – 4:00PM Research Track
Maryann Amirshahi, Stephanie Carrreiro, Neeraj Chhabra, & Rachel Culbreth	Original Research	Advancing Medical Toxicology: Establishing a Strategic Research Agenda for ACMT	4/4 at 1:55 – 2:40PM Research Track
Paul Wax, Alex Krotulski, Rachel Culbreth, Jeffrey Brent	Original Research	How Can the Quantification of Blood Drug Concentrations Improve our Understanding of Non-Fatal Polydrug Overdoses	4/4 at 1:00 – 1:45PM Research Track